Table 5

Prevalence of ‘as needed’ medication prescriptions at end-of-life (EOL) in patients with oxygen-dependent interstitial lung disease (ILD) versus lung cancer

‘As needed’ prescriptionILDLung cancerp Value (χ2 test)
Total nn (%)Total nn (%)
Death rattle243188 (77)10 2479034 (88)<0.001
Pain242200 (83)10 2939830 (96)<0.001
Anxiety239189 (79)10 2629297 (91)<0.001
Nausea239122 (51)10 1767471 (73)<0.001
  • Patients with oxygen-dependent ILD (n=285) or lung cancer (n=10 822). The prevalence (%) of ‘as needed’ prescriptions during the last week of life in Sweden.